Table 1 Clinical characteristics of the two patients before surgery
Patient number | Age/sex | Tumor size (cm) | TNM | Hormone status | HER-2 | NACT regimen | Tumor size (cm) after NACT |
|---|---|---|---|---|---|---|---|
1 | 57/F | 2.1 | T2N1M0 | + | - | Docetaxel + epirubicin | 0.9 |
2 | 41/F | 3.0 | T2N0M0 | + | - | Docetaxel + epirubicin | 0.96 |